The ASX200 retreated by 0.1% on Friday morning, though the index is still close to its record high after yesterday’s 1% rally ...

Market Capitalization Reflects the total market ... Source: FactSet Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any ...

Arafura Rare Earths closed at 13.5 cents. Neuren Pharmaceuticals (ASX:NEU) closed down 8.2% on the news its partner Acadia Pharmaceuticals has submitted a Marketing Authorization Application (MAA ...

Healthcare’s resilience makes it a go-to sector during market volatility. With steady demand, innovation, and aging demographics driving growth, investors could consider investing in fundamentally ...

There wasn't one single sector that didn't participate in the market rally this ... This Thursday's index winner came in at healthcare stock Neuren Pharmaceuticals Ltd (ASX: NEU).

The index’s biggest gainer was Neuren Pharmaceuticals ... noted ClearBridge Investments’ head of economics and market Strategy, Jeff Schulze. He said recent “stronger economic data and ...

It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...

The index’s biggest detractor was Neuren Pharmaceuticals ... of cash via seven-day reverse repurchase agreements in daily open market operations. The operation is aimed at offsetting the ...

The Aussie market closes down despite a positive start to trade across the board, as investors look ahead for jobs data and US inflation updates. Despite early gains, the benchmark ASX 200 index ...

The benchmark S&P/ASX 200 index rallied 113.7 points or 1.38 per cent to 8327 points, while the broader All Ordinaries rose by 112.3 points or 1.33 per cent to 8569.1 points. The Australian dollar ...

At the more established end of the market, US policy moves are muddying ... Dr Storey said he also favoured Neuren Pharmaceuticals, with the share price having come under pressure recently ...